Takeda Pharmaceutical
在场
是其中之一......
Takeda Pharmaceutical 是一家在股票代码 4502 (JP) 下上市的公司。
Takeda Pharmaceutical 在 20 个国家有直接业务。Takeda Pharmaceutical 拥有 21家子公司，其中包括 Takeda Americas、Takeda APAC 和 Takeda Australia。
他们在：
高管
查看带有其 144 名主要高管的组织结构图
Takeda Pharmaceutical 搜索最多的简介
- Christophe Weber, President, Chief Executive Officer and Represent...
- Jean-Luc Butel, Independent Director
- Kimberly Reed, Director
高管在Takeda Pharmaceutical变化
- Christophe Weber, President, Chief Executive Officer and Representative Director, 将于 20266月 退休 (新闻发布的2025一月30号).
- Julie Kim who is President, US Business Unit and US Country Head, will be promoted to Chief Executive Officer in 20266月 (新闻发布的2025一月30号).
创建提醒
跟踪 Takeda Pharmaceutical 的高管变动
药店
Takeda Pharmaceutical 拥有 1,835 家竞争者，其中包括 Pfizer (美国(美洲))、Sanofi (法国) 和 Johnson & Johnson (美国(美洲))。
Popular M&A news in 药店
- Bain Capital 已收购 Mitsubishi Tanabe Pharma (公布2025二月12号).
- Crown Laboratories 已收购 Revance Therapeutics (公布2025二月9号).
- Revance Therapeutics has announced the acquisition of Revance Therapeutics (公布2025一月14号).
药店 行业的其他推荐联系人
消息
Takeda Pharmaceutical 的最新新闻稿
- Takeda to Present Data at American Society of Hematology Annual Meeting
- New colorectal cancer treatment approved in the U.S.
- Takeda Phase 2b TAK-279 data in psoriatic arthritis ACR Convergence
- U.S. FDA Approves Takeda’s Treatment for Ultra-Rare Blood Clotting Disorder
- Notice of the Revised Forecast of Consolidated Financials for FY2023 (IFRS)
- Takeda Announces FY2023 H1 Results; Updates Full-Year Forecasts While Remaining on Track Towards Management Guidance
- Takeda announces topline results of phase 3 ADMIRE-CD II trial of Alofisel®
- ADCETRIS receives EC Approval in Frontline Stage III Hodgkin Lymphoma
- Takeda to Hold 2nd Quarter of FY2023 Earnings Call on October 26
- Takeda Settles Tax Dispute with Irish Revenue over Break Fee Received by Shire
- View more press releases Close
